Guided Therapeutics (GTHP) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Guided Therapeutics (GTHP) over the last 12 years, with Q3 2025 value amounting to $17000.0.

  • Guided Therapeutics' Other Non-Current Assets changed 0.0% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $17000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Guided Therapeutics' Other Non-Current Assets stood at $17000.0, which was down 0.0% from $17000.0 recorded in Q2 2025.
  • Over the past 5 years, Guided Therapeutics' Other Non-Current Assets peaked at $18000.0 during Q1 2021, and registered a low of $17000.0 during Q2 2021.
  • Over the past 5 years, Guided Therapeutics' median Other Non-Current Assets value was $17000.0 (recorded in 2021), while the average stood at $17052.6.
  • Over the last 5 years, Guided Therapeutics' Other Non-Current Assets had its largest YoY gain of 588.24% in 2021, and its largest YoY loss of 9655.17% in 2021.
  • Quarter analysis of 5 years shows Guided Therapeutics' Other Non-Current Assets stood at $17000.0 in 2021, then changed by 0.0% to $17000.0 in 2022, then changed by 0.0% to $17000.0 in 2023, then changed by 0.0% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025.
  • Its Other Non-Current Assets stands at $17000.0 for Q3 2025, versus $17000.0 for Q2 2025 and $17000.0 for Q1 2025.